Nuestros recursos

When it comes to clinical trials, DCT and digital therapeutic (DTx) companies are natural partners. Both are tech savvy and adept in digital health

Decentralized clinical trials offer an effective avenue to mitigate the issues that typify pediatric clinical trials, including patient-reported data accuracy.

Though incidences of pneumonia have decreased overall, the disease is the leading infectious cause of death in children globally, affecting 1 in 6 child deaths.

How do increasingly prevalent DCT methods fit into the existing clinical trial ecosystem? In short: There are complexities. Many eClinical platforms still lack key capabilities, which often require complex integrations with third-party solutions.

The extended partnership includes access to Dedalus’s robust data mining technology to facilitate the ingestion, harmonization, and analysis of patient data.

In our conversations with trial sponsors, ObvioHealth often tackles common misconceptions about decentralized clinical trials (DCTs). These myths hinder our industry’s evolution by keeping sponsors from designing optimal trials that deliver better data with higher retention and compliance rates.

Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.